These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24730)

  • 1. [3H]Dihydroergocryptine binding to alpha adrenergic receptors in canine aortic membranes.
    Tsai BS; Lefkowitz RJ
    J Pharmacol Exp Ther; 1978 Mar; 204(3):606-14. PubMed ID: 24730
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha adrenergic receptors in beef aortic membranes characterised by [3H] dihydroergocryptine binding.
    Carman-Krzan M
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):237-50. PubMed ID: 6254455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alpha-adrenergic receptors in guinea-pig vas deferens by [3H]dihydroergocryptine binding.
    Holck MI; Marks BH; Wilberding CA
    Mol Pharmacol; 1979 Jul; 16(1):77-90. PubMed ID: 225655
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacological classification of adrenergic alpha 1 and alpha 2 receptors and their mechanisms of action.
    Wikberg JE
    Acta Physiol Scand Suppl; 1979; 468():1-99. PubMed ID: 42274
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta.
    Ruffolo RR; Rosing EL; Waddell JE
    J Pharmacol Exp Ther; 1979 Jun; 209(3):429-36. PubMed ID: 35606
    [No Abstract]   [Full Text] [Related]  

  • 6. Agonist versus antagonist binding to alpha-adrenergic receptors.
    Hoffman BB; Michel T; Kilpatrick DM; Lefkowitz RJ; Tolbert ME; Gilman H; Fain JN
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4569-73. PubMed ID: 6107908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 1-Adrenergic receptors of a smooth muscle cell line: guanine nucleotides do not regulate agonist affinities.
    Cornett LE; Ball DW; Norris JS
    J Recept Res; 1981-1982; 2(5-6):601-15. PubMed ID: 6130152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens.
    Wilberding CA; Marks BH
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):387-401. PubMed ID: 6265988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha noradrenergic receptors in rat brain membranes.
    Greenberg DA; Snyder SH
    Mol Pharmacol; 1978 Jan; 14(1):38-49. PubMed ID: 203845
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization by [3H]dihydroergocryptine binding of alpha-adrenergic receptors in neuroblastoma X glioma hybrid cells.
    Haga T; Haga K
    J Neurochem; 1981 Mar; 36(3):1152-9. PubMed ID: 6110704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle.
    Roberts JM; Goldfien A; Insel PA
    Nature; 1980 Jan; 283(5742):108-9. PubMed ID: 6243174
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
    Williams LT; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):304-13. PubMed ID: 192992
    [No Abstract]   [Full Text] [Related]  

  • 13. The identification of alpha-adrenergic receptors in adipose tissue by [3H]dihydroergocryptine binding.
    Bégin-Heick N; Houlihan PA; Sigouin J
    Can J Biochem; 1979 Jul; 57(7):1047-9. PubMed ID: 226241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for two alpha-adrenergic binding sites in liver plasma membranes. Studies with [3H]epinephrine and [3H]dihydroergocryptine.
    El-Refai MF; Blackmore PF; Exton JH
    J Biol Chem; 1979 Jun; 254(11):4375-86. PubMed ID: 35537
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function.
    Peroutka SJ; Greenberg DA; U'Prichard DC; Snyder SH
    Mol Pharmacol; 1978 May; 14(3):403-12. PubMed ID: 26861
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of subtype selectivity of alpha-adrenergic antagonists: comparison of selective and nonselective radioligands.
    Lavin TN; Hoffman BB; Lefkowitz RJ
    Mol Pharmacol; 1981 Jul; 20(1):28-34. PubMed ID: 6117003
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.
    Titeler M; Seeman P
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2249-53. PubMed ID: 27786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]dihydroergocryptine binding to alpha-adrenoceptors in human femoral veins and arteries.
    Kaiser B; Glusa E; Hoffmann A; Markwardt F
    Biomed Biochim Acta; 1984; 43(4):439-46. PubMed ID: 6148934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the alpha 1-adrenergic receptor subtype in a smooth muscle cell line.
    Cornett LE; Norris JS
    J Biol Chem; 1982 Jan; 257(2):694-7. PubMed ID: 6119313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P; Meyer P
    Br J Pharmacol; 1981 May; 73(1):33-9. PubMed ID: 6269682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.